Does aerobic exercise affect the hypothalamic-pituitary-adrenal hormonal response in patients with fibromyalgia syndrome?

Aysun Genc, Birkan Sonel Tur, Yesim Kurtais Aytur, Derya Oztuna, Murat Faik Erdogan, Aysun Genc, Birkan Sonel Tur, Yesim Kurtais Aytur, Derya Oztuna, Murat Faik Erdogan

Abstract

[Purpose] The hypothalamic-pituitary-adrenal (HPA) axis in the etiopathogenesis of fibromyalgia is not clear. This study aimed to analyze the effects of a 6-week aerobic exercise program on the HPA axis in patients with fibromyalgia and to investigate the effects of this program on the disease symptoms, patients' fitness, disability, and quality of life. [Subjects and Methods] Fifty fibromyalgia patients were randomized to Group 1 (stretching and flexibility exercises at home for 6 weeks) and Group 2 (aerobic exercise three times a week and the same at-home exercises as Group 1 for 6 weeks). Serum levels of cortisol, adrenocorticotropic hormone, insulin-like growth factor-1, and growth hormone were analyzed at baseline and at the end of, and 1 hr after an exercise stress test. [Results] Group 2 showed better improvement in morning stiffness duration and pain. Growth hormone levels significantly increased after intervention and cortisol levels significantly decreased at time-time interaction in both groups. No significant differences in adrenocorticotropic hormone and insulin-like growth factor-1 were found. [Conclusion] The results of this study seem to support the hypothesis that there is a dysregulation of the HPA axis in patients with FM, and that a six-week exercise program can influence symptoms and affect the HPA axis hormones.

Keywords: Aerobic exercise; Fibromyalgia; Hypothalamic-pituitary-adrenal axis.

Figures

Fig. 1.
Fig. 1.
Flow chart *The reasons for exclusion from the study

References

    1. Bennett RM, Jones J, Turk DC, et al. : An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord, 2007, 8: 27.
    1. Crofford LJ, Pillemer SR, Kalogeras KT, et al. : Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum, 1994, 37: 1583–1592.
    1. Adler GK, Kinsley BT, Hurwitz S, et al. : Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med, 1999, 106: 534–543.
    1. Wingenfeld K, Nutzinger D, Kauth J, et al. : Salivary cortisol release and hypothalamic pituitary adrenal axis feedback sensitivity in fibromyalgia is associated with depression but not with pain. J Pain, 2010, 11: 1195–1202.
    1. Riva R, Mork PJ, Westgaard RH, et al. : Fibromyalgia syndrome is associated with hypocortisolism. Int J Behav Med, 2010, 17: 223–233.
    1. Cuatrecasas G, Gonzalez MJ, Alegre C, et al. : High prevalence of growth hormone deficiency in severe fibromyalgia syndromes. J Clin Endocrinol Metab, 2010, 95: 4331–4337.
    1. Crofford LJ, Demitrack MA: Evidence that abnormalities of central neurohormonal systems are key to understanding fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am, 1996, 22: 267–284.
    1. Thomas EN, Blotman F: Aerobic exercise in fibromyalgia: a practical review. Rheumatol Int, 2010, 30: 1143–1150.
    1. Vural M, Berkol TD, Erdogdu Z, et al. : Evaluation of the effectiveness of an aerobic exercise program and the personality characteristics of patients with fibromyalgia syndrome: a pilot study. J Phys Ther Sci, 2014, 26: 1561–1565.
    1. Kjaer M, Dela FM: Endocrine responses to exercise. In: Goetz-Hoffman L, ed. Exercise and immune function. Florida: CRC Press, 1996, pp 1–19.
    1. Hill EE, Zack E, Battaglini C, et al. : Exercise and circulating cortisol levels: the intensity threshold effect. J Endocrinol Invest, 2008, 31: 587–591.
    1. Valim V, Oliveira L, Suda A, et al. : Aerobic fitness effects in fibromyalgia. J Rheumatol, 2003, 30: 1060–1069.
    1. Ortega E, García JJ, Bote ME, et al. : Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances. Exerc Immunol Rev, 2009, 15: 42–65.
    1. Gürsel Y, Ergin S, Ulus Y, et al. : Hormonal responses to exercise stress test in patients with fibromyalgia syndrome. Clin Rheumatol, 2001, 20: 401–405.
    1. Wolfe F, Smythe HA, Yunus MB, et al. : The American College of Rheumatology 1990 criteria for the classification of Fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum, 1990, 33: 160–172.
    1. Aloisi AM, Buonocore M, Merlo L, et al. : Chronic pain therapy and hypothalamic-pituitary-adrenal axis impairment. Psychoneuroendocrinology, 2011, 36: 1032–1039.
    1. Burckhardt CS, Clark SR, Bennett RM: The fibromyalgia impact questionnaire: development and validation. J Rheumatol, 1991, 18: 728–733.
    1. Sarmer S, Ergin S, Yavuzer G: The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int, 2000, 20: 9–12.
    1. Ware JE, Jr: SF-36 health survey update. Spine, 2000, 25: 3130–3139.
    1. Koçyiğit H, Aydemir Ö, Fişek G: Kısa form-36 (KF-36)’nın Türkçe versiyonunun güvenirliliği ve geçerliliği. İlaç ve Tedavi Dergisi, 1999,. 12: 102–106.
    1. Kurtais Y, Tur BS, Elhan AH, et al. : Hypothalamic-pituitary-adrenal hormonal responses to exercise stress test in patients with rheumatoid arthritis compared to healthy controls. J Rheumatol, 2006, 33: 1530–1537.
    1. Beaver WL, Wasserman K, Whipp BJ: A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1985, 1986, 60: 2020–2027.
    1. Arnold B, Häuser W, Arnold M, et al. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften: [Multicomponent therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline]. Schmerz, 2012, 26: 287–290.
    1. Mannerkorpi K, Nordeman L, Cider A, et al. : Does moderate-to-high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial. Arthritis Res Ther, 2010, 12: R189.
    1. Bircan C, Karasel SA, Akgün B, et al. : Effects of muscle strengthening versus aerobic exercise program in fibromyalgia. Rheumatol Int, 2008, 28: 527–532.
    1. Mengshoel AM, Komnaes HB, Førre O: The effects of 20 weeks of physical fitness training in female patients with fibromyalgia. Clin Exp Rheumatol, 1992, 10: 345–349.
    1. Ross RL, Jones KD, Bennett RM, et al. : Preliminary evidence of increased pain and elevated cytokines in fibromyalgia patients with defective growth hormone response to exercise. Open Immunol J, 2010, 3: 9–18.
    1. Mehta A, Hindmarsh PC: The use of somatropin (recombinant growth hormone) in children of short stature. Paediatr Drugs, 2002, 4: 37–47.
    1. Moldofsky H, Scarisbrick P, England R, et al. : Musculosketal symptoms and non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med, 1975, 37: 341–351.
    1. Jones KD, Deodhar P, Lorentzen A, et al. : Growth hormone perturbations in fibromyalgia: a review. Semin Arthritis Rheum, 2007, 36: 357–379.
    1. Jacobsen S, Main K, Danneskiold-Samsøe B, et al. : A controlled study on serum insulin-like growth factor-I and urinary excretion of growth hormone in fibromyalgia. J Rheumatol, 1995, 22: 1138–1140.
    1. Buchwald D, Umali J, Stene M: Insulin-like growth factor-I (somatomedin C) levels in chronic fatigue syndrome and fibromyalgia. J Rheumatol, 1996, 23: 739–742.
    1. Berg U, Bang P: Exercise and circulating insulin-like growth factor I. Horm Res, 2004, 62: 50–58.
    1. Jones KD, Deodhar AA, Burckhardt CS, et al. : A combination of 6 months of treatment with pyridostigmine and triweekly exercise fails to improve insulin-like growth factor-I levels in fibromyalgia, despite improvement in the acute growth hormone response to exercise. J Rheumatol, 2007, 34: 1103–1111.
    1. Kirnap M, Colak R, Eser C, et al. : A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome. Clin Endocrinol (Oxf), 2001, 55: 455–459.
    1. Riedel W, Layka H, Neeck G: Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones. Z Rheumatol, 1998, 57: 81–87.
    1. Riedel W, Schlapp U, Leck S, et al. : Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein. Ann N Y Acad Sci, 2002, 966: 483–490.
    1. Wingenfeld K, Heim C, Schmidt I, et al. : HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psychosom Med, 2008, 70: 65–72.
    1. Catley D, Kaell AT, Kirschbaum C, et al. : A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res, 2000, 13: 51–61.
    1. Gur A, Cevik R, Sarac AJ, et al. : Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis, 2004, 63: 1504–1506.
    1. Maes M, Lin A, Bonaccorso S, et al. : Increased 24-hour urinary cortisol excretion in patients with post-traumatic stress disorder and patients with major depression, but not in patients with fibromyalgia. Acta Psychiatr Scand, 1998, 98: 328–335.
    1. McLean SA, Williams DA, Harris RE, et al. : Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum, 2005, 52: 3660–3669.
    1. Pollock M, Gaesser GA, Butcher JD, et al. : The recommend quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc, 1998, 30: 975–991.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe